0
     

Report Added
Report already added
Tick-borne Encephalitis Vaccine Market - Global Outlook and Forecast 2022-2028

Tick-borne Encephalitis Vaccine Market - Global Outlook and Forecast 2022-2028

The major factors that drive the growth of global tick-borne encephalitis vaccine, inactivated market is rise in prevalence of tick-borne encephalitis, especially in Europe, and increased government funding on healthcare facilities. In addition, increase in drug development owing to technological advancement in the medical sector fuels the market growth. However, high cost of vaccines is the major restraint of the market. On the contrary, untapped economies with unmet medical needs is anticipated to provide lucrative opportunities for market growth.
This report contains market size and forecasts of Tick-borne Encephalitis Vaccine in global, including the following market information:

Global Tick-borne Encephalitis Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tick-borne Encephalitis Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Tick-borne Encephalitis Vaccine companies in 2021 (%)
The global Tick-borne Encephalitis Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
European TBE Virus Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tick-borne Encephalitis Vaccine include Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus and Superdrug Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tick-borne Encephalitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Tick-borne Encephalitis Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Tick-borne Encephalitis Vaccine Market Segment Percentages, by Type, 2021 (%)
European TBE Virus
Far Eastern TBE Virus
Siberian TBE Virus
Global Tick-borne Encephalitis Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Tick-borne Encephalitis Vaccine Market Segment Percentages, by Application, 2021 (%)
Pediatric Vaccines
Adult Vaccines
Traveler Vaccines
Global Tick-borne Encephalitis Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Tick-borne Encephalitis Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tick-borne Encephalitis Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tick-borne Encephalitis Vaccine revenues share in global market, 2021 (%)
Key companies Tick-borne Encephalitis Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Tick-borne Encephalitis Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Encephalitis
Cochrane Collaboration
Sonic HealthPlus
Superdrug Health
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Tick-borne Encephalitis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tick-borne Encephalitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tick-borne Encephalitis Vaccine Overall Market Size
2.1 Global Tick-borne Encephalitis Vaccine Market Size: 2021 VS 2028
2.2 Global Tick-borne Encephalitis Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Tick-borne Encephalitis Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Tick-borne Encephalitis Vaccine Players in Global Market
3.2 Top Global Tick-borne Encephalitis Vaccine Companies Ranked by Revenue
3.3 Global Tick-borne Encephalitis Vaccine Revenue by Companies
3.4 Global Tick-borne Encephalitis Vaccine Sales by Companies
3.5 Global Tick-borne Encephalitis Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Tick-borne Encephalitis Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Tick-borne Encephalitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tick-borne Encephalitis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Tick-borne Encephalitis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Tick-borne Encephalitis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tick-borne Encephalitis Vaccine Market Size Markets, 2021 & 2028
4.1.2 European TBE Virus
4.1.3 Far Eastern TBE Virus
4.1.4 Siberian TBE Virus
4.2 By Type - Global Tick-borne Encephalitis Vaccine Revenue & Forecasts
4.2.1 By Type - Global Tick-borne Encephalitis Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Tick-borne Encephalitis Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Tick-borne Encephalitis Vaccine Sales & Forecasts
4.3.1 By Type - Global Tick-borne Encephalitis Vaccine Sales, 2017-2022
4.3.2 By Type - Global Tick-borne Encephalitis Vaccine Sales, 2023-2028
4.3.3 By Type - Global Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Tick-borne Encephalitis Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Tick-borne Encephalitis Vaccine Market Size, 2021 & 2028
5.1.2 Pediatric Vaccines
5.1.3 Adult Vaccines
5.1.4 Traveler Vaccines
5.2 By Application - Global Tick-borne Encephalitis Vaccine Revenue & Forecasts
5.2.1 By Application - Global Tick-borne Encephalitis Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Tick-borne Encephalitis Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Tick-borne Encephalitis Vaccine Sales & Forecasts
5.3.1 By Application - Global Tick-borne Encephalitis Vaccine Sales, 2017-2022
5.3.2 By Application - Global Tick-borne Encephalitis Vaccine Sales, 2023-2028
5.3.3 By Application - Global Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Tick-borne Encephalitis Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Tick-borne Encephalitis Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Tick-borne Encephalitis Vaccine Revenue & Forecasts
6.2.1 By Region - Global Tick-borne Encephalitis Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Tick-borne Encephalitis Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Tick-borne Encephalitis Vaccine Sales & Forecasts
6.3.1 By Region - Global Tick-borne Encephalitis Vaccine Sales, 2017-2022
6.3.2 By Region - Global Tick-borne Encephalitis Vaccine Sales, 2023-2028
6.3.3 By Region - Global Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Tick-borne Encephalitis Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Tick-borne Encephalitis Vaccine Sales, 2017-2028
6.4.3 US Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.4.4 Canada Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.4.5 Mexico Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Tick-borne Encephalitis Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Tick-borne Encephalitis Vaccine Sales, 2017-2028
6.5.3 Germany Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.5.4 France Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.5.5 U.K. Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.5.6 Italy Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.5.7 Russia Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.5.9 Benelux Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Tick-borne Encephalitis Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Tick-borne Encephalitis Vaccine Sales, 2017-2028
6.6.3 China Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.6.4 Japan Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.6.5 South Korea Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.6.7 India Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Tick-borne Encephalitis Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Tick-borne Encephalitis Vaccine Sales, 2017-2028
6.7.3 Brazil Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.7.4 Argentina Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Sales, 2017-2028
6.8.3 Turkey Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.8.4 Israel Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Tick-borne Encephalitis Vaccine Market Size, 2017-2028
6.8.6 UAE Tick-borne Encephalitis Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Tick-borne Encephalitis Vaccine Major Product Offerings
7.1.4 Pfizer Tick-borne Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Encephalitis
7.2.1 Encephalitis Corporate Summary
7.2.2 Encephalitis Business Overview
7.2.3 Encephalitis Tick-borne Encephalitis Vaccine Major Product Offerings
7.2.4 Encephalitis Tick-borne Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Encephalitis Key News
7.3 Cochrane Collaboration
7.3.1 Cochrane Collaboration Corporate Summary
7.3.2 Cochrane Collaboration Business Overview
7.3.3 Cochrane Collaboration Tick-borne Encephalitis Vaccine Major Product Offerings
7.3.4 Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Cochrane Collaboration Key News
7.4 Sonic HealthPlus
7.4.1 Sonic HealthPlus Corporate Summary
7.4.2 Sonic HealthPlus Business Overview
7.4.3 Sonic HealthPlus Tick-borne Encephalitis Vaccine Major Product Offerings
7.4.4 Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sonic HealthPlus Key News
7.5 Superdrug Health
7.5.1 Superdrug Health Corporate Summary
7.5.2 Superdrug Health Business Overview
7.5.3 Superdrug Health Tick-borne Encephalitis Vaccine Major Product Offerings
7.5.4 Superdrug Health Tick-borne Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Superdrug Health Key News
8 Global Tick-borne Encephalitis Vaccine Production Capacity, Analysis
8.1 Global Tick-borne Encephalitis Vaccine Production Capacity, 2017-2028
8.2 Tick-borne Encephalitis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Tick-borne Encephalitis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tick-borne Encephalitis Vaccine Supply Chain Analysis
10.1 Tick-borne Encephalitis Vaccine Industry Value Chain
10.2 Tick-borne Encephalitis Vaccine Upstream Market
10.3 Tick-borne Encephalitis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tick-borne Encephalitis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Tick-borne Encephalitis Vaccine in Global Market
Table 2. Top Tick-borne Encephalitis Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Tick-borne Encephalitis Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Tick-borne Encephalitis Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Tick-borne Encephalitis Vaccine Sales by Companies, (K Doses), 2017-2022
Table 6. Global Tick-borne Encephalitis Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Tick-borne Encephalitis Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Tick-borne Encephalitis Vaccine Product Type
Table 9. List of Global Tier 1 Tick-borne Encephalitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tick-borne Encephalitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Tick-borne Encephalitis Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Tick-borne Encephalitis Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Tick-borne Encephalitis Vaccine Sales (K Doses), 2017-2022
Table 15. By Type - Global Tick-borne Encephalitis Vaccine Sales (K Doses), 2023-2028
Table 16. By Application – Global Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Tick-borne Encephalitis Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Tick-borne Encephalitis Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Tick-borne Encephalitis Vaccine Sales (K Doses), 2017-2022
Table 20. By Application - Global Tick-borne Encephalitis Vaccine Sales (K Doses), 2023-2028
Table 21. By Region – Global Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Tick-borne Encephalitis Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Tick-borne Encephalitis Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Tick-borne Encephalitis Vaccine Sales (K Doses), 2017-2022
Table 25. By Region - Global Tick-borne Encephalitis Vaccine Sales (K Doses), 2023-2028
Table 26. By Country - North America Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Tick-borne Encephalitis Vaccine Sales, (K Doses), 2017-2022
Table 29. By Country - North America Tick-borne Encephalitis Vaccine Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Tick-borne Encephalitis Vaccine Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Tick-borne Encephalitis Vaccine Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Tick-borne Encephalitis Vaccine Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Tick-borne Encephalitis Vaccine Sales, (K Doses), 2023-2028
Table 38. By Country - South America Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Tick-borne Encephalitis Vaccine Sales, (K Doses), 2017-2022
Table 41. By Country - South America Tick-borne Encephalitis Vaccine Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Sales, (K Doses), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Tick-borne Encephalitis Vaccine Product Offerings
Table 48. Pfizer Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Encephalitis Corporate Summary
Table 50. Encephalitis Tick-borne Encephalitis Vaccine Product Offerings
Table 51. Encephalitis Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Cochrane Collaboration Corporate Summary
Table 53. Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Offerings
Table 54. Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Sonic HealthPlus Corporate Summary
Table 56. Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Offerings
Table 57. Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Superdrug Health Corporate Summary
Table 59. Superdrug Health Tick-borne Encephalitis Vaccine Product Offerings
Table 60. Superdrug Health Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Tick-borne Encephalitis Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 62. Global Tick-borne Encephalitis Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Tick-borne Encephalitis Vaccine Production by Region, 2017-2022 (K Doses)
Table 64. Global Tick-borne Encephalitis Vaccine Production by Region, 2023-2028 (K Doses)
Table 65. Tick-borne Encephalitis Vaccine Market Opportunities & Trends in Global Market
Table 66. Tick-borne Encephalitis Vaccine Market Drivers in Global Market
Table 67. Tick-borne Encephalitis Vaccine Market Restraints in Global Market
Table 68. Tick-borne Encephalitis Vaccine Raw Materials
Table 69. Tick-borne Encephalitis Vaccine Raw Materials Suppliers in Global Market
Table 70. Typical Tick-borne Encephalitis Vaccine Downstream
Table 71. Tick-borne Encephalitis Vaccine Downstream Clients in Global Market
Table 72. Tick-borne Encephalitis Vaccine Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Tick-borne Encephalitis Vaccine Segment by Type
Figure 2. Tick-borne Encephalitis Vaccine Segment by Application
Figure 3. Global Tick-borne Encephalitis Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tick-borne Encephalitis Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tick-borne Encephalitis Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Tick-borne Encephalitis Vaccine Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Tick-borne Encephalitis Vaccine Revenue in 2021
Figure 9. By Type - Global Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Tick-borne Encephalitis Vaccine Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Tick-borne Encephalitis Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 19. US Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 33. China Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Tick-borne Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Tick-borne Encephalitis Vaccine Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Tick-borne Encephalitis Vaccine by Region, 2021 VS 2028
Figure 50. Tick-borne Encephalitis Vaccine Industry Value Chain
Figure 51. Marketing Channels

Report Title: Tick-borne Encephalitis Vaccine Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update